Doron Shohet
About Doron Shohet
Doron Shohet is a financial planning and analysis analyst currently serving as the associate director of global business development and strategy in the mergers and acquisitions team at Teva Pharmaceuticals. He has a background in consulting and auditing from his time at PwC and holds an MBA from Tel Aviv University.
Current Role at Teva Pharmaceuticals
Doron Shohet serves as the Associate Director of Global Business Development and Strategy within the M&A team at Teva Pharmaceuticals. He has held this position since 2016, contributing to the company's strategic initiatives and mergers and acquisitions. His role involves analyzing market trends and identifying potential business opportunities to enhance Teva's growth and competitiveness in the pharmaceutical industry.
Previous Experience at PwC
Doron Shohet has extensive experience at PwC, where he worked in various capacities. He served as a Senior Auditor from 2012 to 2015, focusing on financial audits and compliance. In 2016, he briefly worked as a Valuation Consultant for three months, providing insights into asset valuations. Additionally, he worked as a Strategy Consultant for one year, from 2015 to 2016, where he supported clients in developing strategic plans.
Education and Expertise
Doron Shohet holds a Master of Business Administration (MBA) from Tel Aviv University, which he completed from 2014 to 2015. He also earned a Bachelor of Arts degree from the Israel College of Management, where he studied from 2009 to 2012. His educational background provides a strong foundation in business principles, finance, and strategic management.
Professional Background
Doron Shohet's professional background includes a blend of finance, strategy, and consulting roles. His career began at PwC, where he gained experience in auditing and valuation before transitioning to strategic consulting. Since joining Teva Pharmaceuticals, he has focused on global business development and strategy, particularly in the mergers and acquisitions sector.